1-[5-(二甲基氨基)-2-吡啶基]乙酮 | 214701-20-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 1-[5-(二甲基氨基)-2-吡啶基]乙酮
• 英文名称: 1-(5-(dimethylamino)pyridin-2-yl)ethanone
• 英文别名: 1-(5-dimethylaminopyridin-2-yl)ethanone；1-[5-(dimethylamino)pyridin-2-yl]ethanone
• CAS: 214701-20-9
• 化学式: C₉H₁₂N₂O
• 分子量: 164.207
• InChiKey: IYQKIZCYJUVVAE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  33.2
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-[5-(二甲基氨基)-2-吡啶基]乙酮 在 乙酸铵 作用下， 以 1,2-二氯乙烷 为溶剂， 生成 5-(3-Bromophenyl)-7-[5-(dimethylamino)pyridin-2-yl]pyrido[2,3-d]pyrimidin-4-amine
  参考文献：
  名称：

  5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure–activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors

  摘要：

  4-Amino-5,7-disubstituted pyridopyrimidines are potent, non-nucleoside inhibitors of adenosine kinase (AK). We recently identified a potent, orally efficacious analog, 4 containing a 7-pyridylmorpholine substituted ring system as the key structural element of this template. In this report, we disclose the pharmacologic effects of five- and six-membered heterocyclic ring replacements for the pyridine ring in 4. These replacements were found to have interesting effects on in vivo efficacy and genotoxicity as well as in vitro potency. We discovered that the nitrogen in the heterocyclic ring at C(7) is important for the modulation of mutagenic side effects (Ames assay). (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2005.03.023
• 作为产物：
  描述：

  N,N-二甲基吡啶-3-胺 在 bis-triphenylphosphine-palladium(II) chloride 、 N-溴代丁二酰亚胺(NBS) 、 copper(l) iodide 、 硫酸 、 mercuric triflate 、 三乙胺 作用下， 以 二氯甲烷 、 水 、 丙酮 、 乙腈 为溶剂， 反应 55.0h， 生成 1-[5-(二甲基氨基)-2-吡啶基]乙酮
  参考文献：
  名称：

  5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine: structure–activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors

  摘要：

  4-Amino-5,7-disubstituted pyridopyrimidines are potent, non-nucleoside inhibitors of adenosine kinase (AK). We recently identified a potent, orally efficacious analog, 4 containing a 7-pyridylmorpholine substituted ring system as the key structural element of this template. In this report, we disclose the pharmacologic effects of five- and six-membered heterocyclic ring replacements for the pyridine ring in 4. These replacements were found to have interesting effects on in vivo efficacy and genotoxicity as well as in vitro potency. We discovered that the nitrogen in the heterocyclic ring at C(7) is important for the modulation of mutagenic side effects (Ames assay). (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2005.03.023

文献信息

• 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
  申请人：——

  公开号：US20030229079A1

  公开（公告）日：2003-12-11

  Certain 1-(aromatic- or heteroaromatic-substituted-3-(heteroaromatic substituted)-1,3-propanediones are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.

  某些1-(芳香基或杂芳基取代的3-(杂芳基取代)-1,3-丙二酮被描述为HIV整合酶的抑制剂和HIV复制的抑制剂。这些化合物在预防或治疗HIV感染以及治疗艾滋病方面是有用的，无论是作为化合物、药学上可接受的盐、药用组合成分，无论是否与其他抗病毒药物、免疫调节剂、抗生素或疫苗结合使用。还描述了治疗艾滋病的方法以及预防或治疗HIV感染的方法。
• Synthesis and In Vitro Evaluation of Imidazo[1,2-<i>b</i>]pyridazines as Ligands for β-Amyloid Plaques
  作者：Fanxing Zeng、David Alagille、Gilles D. Tamagnan、Brian J. Ciliax、Allan I. Levey、Mark M. Goodman

  DOI：10.1021/ml100005j

  日期：2010.5.13

  A series of imidazo[1,2-b]pyridazine derivatives were synthesized and evaluated for binding to amyloid plaques in vitro using synthetic aggregates of A beta(1-40). Binding affinities of these compounds were found to range from 11.0 to > 1000 nM, depending on the various substitution patterns in the 6-position and 2-position. 2 -(4'-Dimethylaminophenyl)-6-(methylthio)imidazo[1,2-b]pyridazine (4) showed high binding affinity (K(i) = 11.0 nM) and might be useful for the development of novel positron emission tomography radiotracers for imaging A beta plaques.
• 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF
  申请人：Merck & Co., Inc.

  公开号：EP1196384A1

  公开（公告）日：2002-04-17
• EP1196384A4
  申请人：——

  公开号：EP1196384A4

  公开（公告）日：2002-10-23
• [EN] 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF<br/>[FR] 1,3-PROPANEDIONES-1-(AROMATIQUES OU HETEROAROMATIQUES SUBSTITUTEES)-3-(HETEROAROMATIQUES SUBSTITUEES) ET LEUR UTILISATION
  申请人：MERCK & CO INC

  公开号：WO2001000578A1

  公开（公告）日：2001-01-04

  Certain 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.